Vasculitic rash
(UMLS:C0521161)
- UMLS ID:
- C0521161
- MeSH ID:
- N/A
Synonym(s)
1.
Vasculitic rash
2.
Vasculitic eruption
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Raltegravir Potassium | FAERS: 5 | US FAERS | |
| 2 | Rivaroxaban | FAERS: 3 | US FAERS | |
| 3 | Atorvastatin | FAERS: 2 | US FAERS | |
| 4 | Benztropine | FAERS: 2 | US FAERS | |
| 5 | Bortezomib | FAERS: 2 | US FAERS | |
| 6 | Clopidogrel | FAERS: 2 | US FAERS | |
| 7 | Exenatide | FAERS: 2 | US FAERS | |
| 8 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 9 | Ibandronic Acid | FAERS: 2 | US FAERS | |
| 10 | Isotretinoin | FAERS: 2 | US FAERS | |
| 11 | Leflunomide | FAERS: 2 | US FAERS | |
| 12 | MDV 3100 | FAERS: 2 | US FAERS | |
| 13 | Methylphenidate | FAERS: 2 | US FAERS | |
| 14 | Pramipexole | FAERS: 2 | US FAERS | |
| 15 | Sunitinib | FAERS: 2 | US FAERS | |
| 16 | Warfarin | FAERS: 2 | US FAERS | |
| 17 | Alendronate | FAERS: 1 | US FAERS | |
| 18 | Anastrozole | FAERS: 1 | US FAERS | |
| 19 | Carbamazepine | FAERS: 1 | US FAERS | |
| 20 | Ciprofloxacin | FAERS: 1 | US FAERS | |
| 21 | Clarithromycin | FAERS: 1 | US FAERS | |
| 22 | Cytarabine | FAERS: 1 | OFFSIDES US FAERS | |
| 23 | Deferasirox | FAERS: 1 | US FAERS | |
| 24 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 25 | Dutasteride | FAERS: 1 | US FAERS | |
| 26 | Epoprostenol | FAERS: 1 | US FAERS | |
| 27 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 28 | Febuxostat | FAERS: 1 | US FAERS | |
| 29 | Fluticasone | FAERS: 1 | US FAERS | |
| 30 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 31 | Hemin | FAERS: 1 | US FAERS | |
| 32 | Hydroxyurea | FAERS: 1 | US FAERS | |
| 33 | Linezolid | FAERS: 1 | US FAERS | |
| 34 | Norfloxacin | FAERS: 1 | US FAERS | |
| 35 | Norgestrel | FAERS: 1 | US FAERS | |
| 36 | Oseltamivir | FAERS: 1 | US FAERS | |
| 37 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 38 | Telmisartan | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 39 | Terbinafine | FAERS: 1 | US FAERS | |
| 40 | Teriparatide | FAERS: 1 | US FAERS | |
| 41 | Tranexamic Acid | FAERS: 1 | US FAERS | |
| 42 | Trimethoprim, Sulfamethoxazole Drug Combination | FAERS: 1 | US FAERS | |
| 43 | Trimethoprim | FAERS: 1 | US FAERS | |
| 44 | Valsartan | FAERS: 1 | US FAERS | |
| 45 | apixaban | FAERS: 1 | US FAERS | |
| 46 | atovaquone, proguanil drug combination | FAERS: 1 | OFFSIDES US FAERS | |
| 47 | candesartan cilexetil | FAERS: 1 | US FAERS | |
| 48 | candesartan | FAERS: 1 | US FAERS | |
| 49 | cefuroxime axetil | FAERS: 1 | US FAERS | |
| 50 | indacaterol | FAERS: 1 | US FAERS | |
| 51 | pomalidomide | FAERS: 1 | US FAERS | |
| 52 | ropinirole | FAERS: 1 | OFFSIDES US FAERS | |
| 53 | telmisartan, hydrochlorothiazide drug combination | FAERS: 1 | US FAERS | |
| 54 | tofacitinib | FAERS: 1 | US FAERS | |
| 55 | Benztropine | OFFSIDES | ||
| 56 | Danazol | OFFSIDES | ||
| 57 | Dioctyl Sulfosuccinic Acid | OFFSIDES | ||
| 58 | Epoprostenol | OFFSIDES | ||
| 59 | Floxacillin | OFFSIDES | ||
| 60 | Folic Acid | OFFSIDES | ||
| 61 | Formoterol Fumarate | OFFSIDES | ||
| 62 | Hydromorphone | OFFSIDES | ||
| 63 | Hydroxychloroquine | OFFSIDES | ||
| 64 | Methotrexate | OFFSIDES | ||
| 65 | Nortriptyline | OFFSIDES | ||
| 66 | Ofloxacin | OFFSIDES | ||
| 67 | Perindopril | OFFSIDES | ||
| 68 | Prochlorperazine | OFFSIDES | ||
| 69 | Ramipril | OFFSIDES | ||
| 70 | Ranolazine | OFFSIDES | ||
| 71 | Terbinafine | OFFSIDES | ||
| 72 | Venlafaxine Hydrochloride | Canada Vigilance: 1 | Canada Vigilance | |
| 73 | entacapone | OFFSIDES | ||
| 74 | exemestane | OFFSIDES | ||
| 75 | gadodiamide | OFFSIDES | ||
| 76 | montelukast | SIDER | ||
| 77 | sibutramine | SIDER | ||
| 78 | valdecoxib | OFFSIDES | ||
| 79 | zafirlukast | SIDER |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.